Daniel Billen

Daniel Billen appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 18 May 2023 to 21 May 2024.

No open-market purchase appears, only 2 sales worth €76k. The rest of the record consists of 1 share grant and 1 option exercise. In 2024 alone, the filings show no purchases and 1 sale.

Most recently, on 22 May 2024, the filings show an open-market sale worth €28k in Aurinia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.